InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,453.91
(
-1.24%
)
US TECH 100
18,484.80
(
-1.90%
)
Dow Jones
40,309.83
(
-1.30%
)
Brent Oil
80.25
(
-1.55%
)
Bitcoin
62,700.68
(
-2.94%
)
Post# of 346155
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

entdoc

Send PM Follow Ignore
Followers 38
Posts 1440
Boards Moderated 0
Alias Born 03/07/2004

entdoc

Re: entdoc post# 161327

Sunday, 02/16/2014 5:18:06 PM

Sunday, February 16, 2014 5:18:06 PM

Post# of 346155
so if we compare Provenge and Bavituximab, one product to one, rather than one marginal product to a vast platform, it seems that Bavituximab will actually have an easier time of it from here on in. Gotta go or I am in trouble! cheers everyone. Yes, dear. I have the car keys.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

FEATURED POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • Aug 1, 2024 9:28 AM

Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM

VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM

Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM

Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM

Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!